Successful immune checkpoint inhibition in an EGFR-mutant lung cancer patient refractory to epidermal growth factor receptor tyrosine kinase inhibitor treatment

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Checkpoint Inhibition ◽

Immune Checkpoint Inhibition ◽

Epidermal Growth ◽

Egfr Mutant ◽

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2019.05.032 ◽

2019 ◽

Vol 117 ◽

pp. 107-115 ◽

Cited By ~ 7

Author(s):

Zong-Han Yao ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

The plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)

Annals of Oncology ◽

10.1093/annonc/mdy292.046 ◽

2018 ◽

Vol 29 ◽

pp. viii514

Author(s):

K. Usui ◽

T. Yokoyama ◽

A. Kisohara ◽

Y. Mori ◽

Y. Takeda ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Tki Treatment ◽

Egfr Mutant ◽

Egfr Tki

Alkaline phosphatase flare phenomenon following epidermal growth factor receptor-tyrosine kinase inhibitor treatment of non-small cell lung cancer: Report of a case and case review

Respiratory Medicine Case Reports ◽

10.1016/j.rmcr.2014.09.003 ◽

2014 ◽

Vol 13 ◽

pp. 51-53 ◽

Cited By ~ 2

Author(s):

Yuko Yasuda ◽

Kodai Kawamura ◽

Kazuya Ichikado ◽

Masakazu Yoshioka

Keyword(s):

Lung Cancer ◽

Alkaline Phosphatase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Case Review ◽

Small Cell Lung ◽

Epidermal Growth ◽

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

Clinical & Translational Oncology ◽

10.1007/s12094-013-1143-9 ◽

2013 ◽

Vol 16 (4) ◽

pp. 339-350 ◽

Cited By ~ 16

Author(s):

S. Carrera ◽

A. Buque ◽

E. Azkona ◽

U. Aresti ◽

B. Calvo ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Treatment Resistance ◽

Therapeutic Strategies ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non–Small-Cell Lung Cancer: The Never-Ending Story

Journal of Clinical Oncology ◽

10.1200/jco.2013.50.2617 ◽

2013 ◽

Vol 31 (26) ◽

pp. 3291-3293 ◽

Cited By ~ 11

Author(s):

Francesco Gelsomino ◽

Francesco Agustoni ◽

Monica Niger ◽

Marika Valota ◽

Eva R. Haspinger

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Epidermal Growth ◽

Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyz023 ◽

2019 ◽

Vol 49 (6) ◽

pp. 554-558 ◽

Cited By ~ 5

Author(s):

Kazuhiro Usui ◽

Takuma Yokoyama ◽

Go Naka ◽

Hiroo Ishida ◽

Kazuma Kishi ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Egfr Mutant ◽

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review

BMC Cancer ◽

10.1186/s12885-019-5309-x ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 6

Author(s):

Takuma Imakita ◽

Hirotaka Matsumoto ◽

Katsuya Hirano ◽

Toshiyuki Morisawa ◽

Azusa Sakurai ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy

Annals of Translational Medicine ◽

10.21037/atm.2018.10.06 ◽

2018 ◽

Vol 6 (20) ◽

pp. 407-407 ◽

Cited By ~ 3

Author(s):

Ye Ning ◽

Minwei Bao ◽

Xiaoxia Yan ◽

Dong Xie ◽

Gening Jiang

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth

Epidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced non-small cell lung cancer with uncommon mutations: A multicenter observational study

Annals of Oncology ◽

10.1093/annonc/mdz437.028 ◽

2019 ◽

Vol 30 ◽

pp. ix169

Author(s):

M. Kanazu ◽

M. Mori ◽

T. Shiroyama ◽

I. Nagatomo ◽

S. Ihara ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Observational Study ◽

Epidermal Growth ◽

Biological Markers for Non–Small Cell Lung Cancer Patient Selection for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-0261 ◽

2006 ◽

Vol 12 (12) ◽

pp. 3652-3656 ◽

Cited By ~ 52

Author(s):

Paul A. Bunn ◽

Rafal Dziadziuszko ◽

Marileila Varella-Garcia ◽

Wilbur A. Franklin ◽

Samir E. Witta ◽

...

Keyword(s):

Lung Cancer ◽

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Tyrosine Kinase Inhibitor Therapy ◽

Epidermal Growth ◽

Selection For